.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Farmers Insurance
Express Scripts
Queensland Health
Citi
Daiichi Sankyo
Cantor Fitzgerald
Accenture
Federal Trade Commission
Boehringer Ingelheim

Generated: January 22, 2018

DrugPatentWatch Database Preview

Drug Master Files for: Iomed

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
2705I7/5/1976SORIN BIOMEDICA SPAMANUFACTURING PROCESS
3285III8/29/1978ALPHA ONE BIOMEDICALS INCSYNTHETIC THYMOSIN (Ro 21-9199)
6069III10/11/1985BIOMED LABORATORIESMANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN SAN DIMAS, CALIFORNIA.
7648III8/25/1988ALPHA ONE BIOMEDICALS INCFACILITIES UTILLIZED AT THE FOSTER CITY, CA LOCATION
9092AII5/1/1991LIFECORE BIOMEDICAL LLCSODIUM HYALURONATE
11609III7/25/1995LIFECORE BIOMEDICAL INCHY-50 HYALURONATE SODIUM STERILE INJECTION
14514III11/5/1999PRONOVA BIOMEDICAL ASMFG SITE FACILITIES OPERATING PROCEDURES AND PERSONEL FOR OSLO NORWAY
15709III11/8/2001BIOMEDISYN CORP(-)-HUPERZINE A AS IMPORTED BY BIOMEDISYN IN WOODBRIDGE, CT
20980AII10/26/2007LIFECORE BIOMEDICALANIMAL COMPONENT FREE SODIUM HYALURONATE
21543AII4/18/2008ABX ADVANCED BIOCHEMICAL COMPOUNDS BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN GMBHMIBG DRUG SUBSTANCE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Accenture
Moodys
Johnson and Johnson
Boehringer Ingelheim
Citi
Farmers Insurance
Fuji
Mallinckrodt
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot